TickerHumNYSE · Healthcare · Medical Devices
Abbott Laboratories (ABT)
As of Nov 11, 4:04 PM ET, Abbott Laboratories (ABT) last traded at $109.29, down 1.06% on the day. Its TickerHum research score is 48/100 (average). It reported revenue of $48.23B for the twelve months ending 2026-09-30, up 10.0% year over year, with a 13.8% operating margin.
Ratings
- Valuation: 60/100 — Strongest input: price / sales (ttm) 3.9x. Weakest: price / earnings (ttm) 40.6x.
- Growth: 25/100 — Strongest input: revenue growth (ttm, yoy) +10.0 %. Weakest: diluted eps growth (ttm, yoy) -66.2 %.
- Profitability: 48/100 — Strongest input: operating margin 13.8 %. Weakest: return on equity 9.2 %.
- Financial health: 41/100 — Strongest input: long-term debt / equity 0.58. Weakest: cash / long-term debt 0.14.
- Momentum: 55/100 — Strongest input: 6-month return +30.4 %. Weakest: 1-year return -15.2 %.
- Attention: 57/100 — Strongest input: headlines in the last 7 days 14. Weakest: volume vs 3-month average 1.0x.
- Risk resilience: 61/100 — Strongest input: annualised volatility (1y) 28.4 %. Weakest: max drawdown (1y) -36.8 %.
- Data confidence: 98/100 — Strongest input: quote age (hours) 14 h. Weakest: inputs available 95 %.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $48.23B | TTM ending 2026-09-30 · 10-Q |
| Revenue growth | 10.0% | TTM ending 2026-09-30 · 10-Q |
| Net income | $4.7B | TTM ending 2026-09-30 · 10-Q |
| Diluted EPS | $2.69 | TTM ending 2026-09-30 · 10-Q |
| Operating margin | 13.8% | TTM ending 2026-09-30 · 10-Q |
| Net margin | 9.7% | TTM ending 2026-09-30 · 10-Q |
| Free cash flow | $6.76B | TTM ending 2026-09-30 · 10-Q |
| Cash | $4.05B | as of 2026-09-30 · 10-Q |
| Long-term debt | $29.45B | as of 2026-09-30 · 10-Q |
| Debt / equity | 0.58 | as of 2026-09-30 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0000001800).
Comparable companies for Abbott Laboratories
Selected by industry, business overlap and scale; these are not necessarily direct competitors.
- Abbott Laboratories vs Medtronic (ABT vs MDT) — Same industry (Medical Devices); market cap 0.69x; shares: medical devices
- Abbott Laboratories vs Stryker (ABT vs SYK) — Same industry (Medical Devices); market cap 0.64x; shares: medical devices
- Abbott Laboratories vs Boston Scientific (ABT vs BSX) — Same industry (Medical Devices); market cap 0.35x; shares: medical devices
- Abbott Laboratories vs Edwards Lifesciences (ABT vs EW) — Same industry (Medical Devices); market cap 0.32x
- Abbott Laboratories vs Becton, Dickinson and (ABT vs BDX) — Same sector (Healthcare), different industry; market cap 0.31x; shares: diagnostics
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.